The reduction in FFA-induced hepatic steatosis in MKRN1-ablated HepG2 cells and the chronic AMPK activation in the livers of MKRN1-null mice led us to investigate the effect of MKRN1 deficiency on HFD-induced NAFLD. Here, PRKAA2 is linked to metabolic dysfunction-associated steatotic liver disease.